Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Federal Administrative Court on the Delineation between Substance-Based Medical Devices and Medicinal Products
CJEU Advocate General on Distributors’ Obligations for Medical Devices
par Jan Feuerhake, LL.M. (Melbourne) et Gabriel Danyeli, LL.M. (Köln/Istanbul Bilgi)
par plusieurs auteurs
par Philippe Glaser et Marie Tavant
par plusieurs auteurs
par Fruzsina Kónya
par Bartosz Świdrak
par Irina Rebin
par Bartosz Świdrak
par Irina Rebin